Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
New heart device aims to cut stroke risk without blood thinners
Disease control TerminatedThis study tests a new device (Laminar) to close off a small pouch in the heart called the left atrial appendage in people with atrial fibrillation. The goal is to reduce the risk of stroke and blood clots. About 1500 participants will be randomly assigned to get either the new d…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
New catheter technique shows promise for controlling irregular heartbeat
Disease control OngoingThis study looks at how well a special catheter (THERMOCOOL SMARTTOUCH®SF) works to treat paroxysmal atrial fibrillation, a condition where the heart beats irregularly. Researchers will track 150 adults for one year to see if the procedure keeps the heart in normal rhythm without…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 26, 2026 05:28 UTC
-
New device offers hope for AFib patients who Can't take blood thinners
Disease control OngoingThis study tests a new device that closes a small pouch in the heart (the left atrial appendage) in people with atrial fibrillation who cannot take blood thinners. The goal is to reduce the risk of stroke without needing lifelong medication. About 58 participants will be enrolled…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC